← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Immurx Llc
Lebanon, NH
$4,683,689
Total funding
6
Grants
Funding over time
peak $1.5M · FY2009–13$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$4,683,689 · 6
By mechanism
R44$2,639,017 · 1
R43$2,044,672 · 5
Investigators at Immurx Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Preclinical Development of a Novel and Powerful Immunotherapeutic$926,922
R44 · FY2011 · AI
Preclinical Development of a Novel and Powerful Immunotherapeutic$864,478
R44 · FY2013 · AI
Preclinical Development of a Novel and Powerful Immunotherapeutic$847,617
R44 · FY2012 · AI
Creation of an Anti-CD40 Superagonistic Monoclonal Antibody$329,936
R43 · FY2009 · AI
Safe and effective anti CD154 antibodies for therapeutic intervention$300,000
R43 · FY2012 · AI
Potent Vaccine Adjuvant Therapeutic$300,000
R43 · FY2009 · AI
Angiogenesis antagonist plus CD40-TLR agonist adjuvant combination vaccine$300,000
R43 · FY2010 · AI
VISTA: A Novel Therapeutic Target That Negatively Regulates Immunity$300,000
R43 · FY2011 · AI
Potent Vaccine Adjuvant Therapeutic$277,222
R43 · FY2010 · AI
Angiogenesis antagonist plus CD40-TLR agonist adjuvant combination vaccine$237,514
R43 · FY2011 · AI